Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial

Venous thromboembolism (VTE) is a frequent complication of cancer associated with morbidity, mortality, increased hospitalizations and higher health care costs. Cancer patients at increased risk for VTE can be identified using a validated risk assessment score, and the incidence of VTE can be reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorana, Alok A., Vadhan-Raj, Saroj, Kuderer, Nicole M., Wun, Ted, Liebman, Howard, Soff, Gerald, Belani, Chandra, O'Reilly, Eileen M., McBane, Robert, Eikelboom, John, Damaraju, C.V, Beyers, Karen, Dietrich, Flavia, Kakkar, Ajay K., Riess, Hanno, Peixoto, Renata D'Alpino, Lyman, Gary H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328370/
https://www.ncbi.nlm.nih.gov/pubmed/28933799
http://dx.doi.org/10.1160/TH17-03-0171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328370/
https://www.ncbi.nlm.nih.gov/pubmed/28933799
http://dx.doi.org/10.1160/TH17-03-0171

Ejemplares similares